Novartis (NVS) is not new to these hallowed pages. Longtime readers (and we appreciate you not pointing out our long absence) will recall that Novartis spun off Alcon(ALC) in April 2019. Last week, however, Novartis completed one of the final steps in its upcoming Sandoz(SDZ) spinoff. At a (fairly ordinary) extraordinary shareholder meeting on September 15, 2023, Novartis… Read More »
Another month is almost in the books so lets recap the recent spinoff activity and also take a look at what spinoffs the next month will bring: Spinoffs Completed Prior Month Some big spinoffs in April. April 1st – after several years of merger integration work, DowDupont (DWDP) began breaking itself up last month with the spin off… Read More »
Last week, Novartis(NVS) completed its spinoff of Alcon(ALC). Less than a decade ago, Novartis had purchased Alcon from Nestle(NSRGY), but new leadership decided to reverse the transaction. In an article this weekend, Barron’s suggests that there is more than meets the eye to Alcon. Barron’s notes that, on the surface, Alcon looks expensive. For now, Wall Street is… Read More »
A cross-country flight transporting a motley collection of violent and dangerous criminals? What could possibly go wrong? Nothing, until they take over the plane mid-air. Good thing Nicholas Cage is there. Oh, wait, that’s Con Air. Really, nothing to do with this morning’s completion of the Alcon (ALC) spinoff from Novartis (NVS), but it’s making us giggle. Go… Read More »
Another month is almost in the books so lets recap the recent spinoff activity and also take a look at what spinoffs the next month will bring: Spinoffs Completed Prior Month It’s worth noting that in February’s roundup, this section had nothing listed. Ooops? It was actually quite a busy month so keep checking our site as we… Read More »
Lets close the week with some Odds & Ends. In this week’s edition, we provide some updates on recent and upcoming spinoffs. We also give thanks to a reader for pointing out something we missed – keep it up! Thanks to reader AH for pointing out that we missed Naspers (NPSNY) spinoff of its Pay-TV business, MultiChoice Group… Read More »
The vision of an independent Alcon is getting closer to reality. As part of its year end earnings release, Novartis (NVS) revealed many more details about the upcoming eye care spinoff which is expected to be completed in the first half of this year. It seems the target is actually sometime in April, but first shareholders will have their… Read More »
Earlier this year Novartis (NVS) CEO Joe Jimenez said the company was considering a sale or a spinoff of Alcon, its surgical equipment and eye care business. The company paid a hefty penny (actually ~$50b worth of pennies) to acquire the business back in 2010, but as with a lot of M&A, things haven’t gone as planned. Many… Read More »
Swiss pharmaceutical giant Novartis (NVS) is considering a spin off Alcon, its surgical equipment and contact lens business. While most of its peers are busy acquiring each other, Novartis is taking a more inward-focused approach also announcing today a $5 billion share buyback. Reporting its 2016 earnings, Novartis said: “Novartis is considering options for the Alcon Division. The… Read More »
GlaxoSmithKline’s (GSK) CEO Sir Andrew Witty recently sat down with the Financial Times and the discussion included some talk about the future of its consumer health business. Although Mr. Witty mentioned that he is open to the idea of a spinoff at some point, the company was not currently pursuing the idea. There has been some spinoff speculation… Read More »